Mourad F H, Barada K A, Abdel-Malak N, Bou Rached N A, Khoury C I, Saade N E, Nassar C F
Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Lebanon.
J Physiol. 2003 Aug 1;550(Pt 3):863-71. doi: 10.1113/jphysiol.2003.043737. Epub 2003 Jun 6.
Nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) interact in the regulation of neuromuscular function in the gut. They are also potent intestinal secretogogues that coexist in the enteric nervous system. The aims of this study were: (1) to investigate the interaction between NO and VIP in inducing fluid secretion in the rat jejunum, and (2) to determine whether the NO effect on intestinal fluid movement is neurally mediated. The single pass perfusion technique was used to study fluid movement in a 25 cm segment of rat jejunum in vivo. A solution containing 20 mM L-arginine, a NO precursor, was perfused into the segment. The effect of the NO synthase inhibitors (L-NAME and L-nitroindazole (L-NI)) and the VIP antagonist ([4Cl-D-Phe6,Leu17]VIP (VIPa)) on L-arginine-induced changes in fluid movement, expressed as microl min(-1) (g dry intestinal weight)(-1), was determined. In addition, the effect of neuronal blockade by tetrodotoxin (TTX) and ablation of the myenteric plexus by benzalkonium chloride (BAC) was studied. In parallel groups of rats, the effect of L-NAME and L-NI on VIP-induced intestinal fluid secretion was also examined. Basal fluid absorption in control rats was (median (interquartile range)) 65 (45-78). L-Arginine induced a significant fluid secretion (-14 (-20 to -5); P<0.01). This effect was reversed completely by L-NAME (60 (36-65); P<0.01) and L-NI (46 (39-75); P<0.01) and partially by VIPa (37 (14-47); P<0.01). TTX and BAC partially inhibited the effect of L-arginine (22 (15-32) and 15 (10-26), respectively; P<0.05). The effect of VIP on fluid movement (-23 (-26 to -14)) was partially reversed by L-NAME (24 (8.4-35.5); P<0.01) and L-NI (29 (4-44); P<0.01). The inhibition of VIP or NO synthase prevented L-arginine- and VIP-induced intestinal fluid secretion through a neural mechanism. The data suggest that NO enhances the release of VIP from nerve terminals and vice versa. Subsequently, each potentiates the other's effect in inducing intestinal fluid secretion.
一氧化氮(NO)和血管活性肠肽(VIP)在肠道神经肌肉功能调节中相互作用。它们也是强效的肠道促分泌素,共存于肠神经系统中。本研究的目的是:(1)研究NO和VIP在诱导大鼠空肠液体分泌中的相互作用,以及(2)确定NO对肠道液体运动的影响是否由神经介导。采用单通道灌注技术研究大鼠空肠25 cm节段在体的液体运动。将含有20 mM L-精氨酸(一种NO前体)的溶液灌注到该节段中。测定了NO合酶抑制剂(L-硝基精氨酸甲酯(L-NAME)和L-硝基吲唑(L-NI))以及VIP拮抗剂([4-氯-D-苯丙氨酸6,亮氨酸17]VIP(VIPa))对L-精氨酸诱导的液体运动变化的影响,以微升·分钟-1·(克干肠重)-1表示。此外,还研究了河豚毒素(TTX)引起的神经阻滞和苯扎氯铵(BAC)对肌间神经丛的切除作用。在平行的大鼠组中,还检测了L-NAME和L-NI对VIP诱导的肠道液体分泌的影响。对照大鼠的基础液体吸收量为(中位数(四分位间距))65(45 - 78)。L-精氨酸诱导了显著的液体分泌(-14(-20至-5);P<0.01)。L-NAME(60(36 - 65);P<0.01)和L-NI(46(39 - 75);P<0.01)完全逆转了这种作用,VIPa部分逆转了这种作用(37(14 - 47);P<0.01)。TTX和BAC部分抑制了L-精氨酸的作用(分别为22(15 - 32)和15(10 - 26);P<0.05)。VIP对液体运动的作用(-23(-26至-14))被L-NAME(24(8.4 - 35.5);P<0.01)和L-NI(29(4 - 44);P<0.01)部分逆转。抑制VIP或NO合酶通过神经机制阻止了L-精氨酸和VIP诱导的肠道液体分泌。数据表明,NO增强了神经末梢VIP的释放,反之亦然。随后,两者在诱导肠道液体分泌中相互增强对方的作用。